CAS 132796-52-2

1,3,8-Trihydroxy-6-methyl-9,10-anthracenedione-d4 1,6,8-Trihydroxy-3-methylanthraquinone-d4 132796-52-2 4,5,7-Trihydroxy-2-methyl-anthraquinone-d4 Archin-d4 Emodin-d4 Emodol-d4 Frangula Emodin-d4 Frangulic Acid-d4 NSC 622947-d4 Rheum Emodin-d4 Schuttgelb-d4

纯度 97%+现货药物标准品
CAS 号132796-52-2
分子式C15H6D4O5
分子量274.26 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

1,3,8-Trihydroxy-6-methyl-9,10-anthracenedione-d4 1,6,8-Trihydroxy-3-methylanthraquinone-d4 132796-52-2 4,5,7-Trihydroxy-2-methyl-anthraquinone-d4 Archin-d4 Emodin-d4 Emodol-d4 Frangula Emodin-d4 Frangulic Acid-d4 NSC 622947-d4 Rheum Emodin-d4 Schuttgelb-d4 CAS 132796-52-2 结构式 Chemical Structure

产品介绍 Description

（1,3,8-Trihydroxy-6-methyl-9,10-anthracenedione-d4 1,6,8-Trihydroxy-3-methylanthraquinone-d4 132796-52-2 4,5,7-Trihydroxy-2-methyl-anthraquinone-d4 Archin-d4 Emodin-d4 Emodol-d4 Frangula Emodin-d4 Frangulic Acid-d4 NSC 622947-d4 Rheum Emodin-d4 Schuttgelb-d4）是药物分析与质量控制领域常用的药物标准品，CAS 号 132796-52-2。分子式 C15H6D4O5，分子量 274.26。纯度 97%+。CATO 佳途拥有 130,000+ 标准品现货目录，可一站式满足配套采购需求。

推荐用于分析方法开发与验证，产品提供完整COA证书，确保ISO 17034标准的量值溯源要求。适用于GLP实验室的日常分析。 CAS编号 132796-52-2 对应的化合物（英文标识 1,3,8-Trihydroxy-6-methyl-9,10-anthracenedione-d4 1,6,8-Trihydroxy-3-methylanthraquinone-d4 132796-52-2 4,5,7-Trihydroxy-2-methyl-anthraquinone-d4 Archin-d4 Emodin-d4 Emodol-d4 Frangula Emodin-d4 Frangulic Acid-d4 NSC 622947-d4 Rheum Emodin-d4 Schuttgelb-d4），化学式 C15H6D4O5，相对分子质量 274.26。 （C15H6D4O5）含有氘代同位素标记，黄酮骨架，含羟基，含醚键。羧基赋予其一定的酸性特征，这些物理化学性质直接决定了其标准溶液的最佳配制方案和储存策略。由于结构中存在共轭发色团，该化合物在200-400 nm区间具

应用场景：（1,3,8-Trihydroxy-6-methyl-9,10-anthracenedione-d4 1,6,8-Trihydroxy-3-methylanthraquinone-d4 132796-52-2 4,5,7-Trihydroxy-2-methyl-anthraquinone-d4 Archin-d4 Emodin-d4 Emodol-d4 Frangula Emodin-d4 Frangulic Acid-d4 NSC 622947-d4 Rheum Emodin-d4 Schuttgelb-d4，CAS 132796-52-2）的标准化应用场景涵盖化学分析等多个专业技术领域。

理化性质 Physical & Chemical Properties

中文名称
分子式C15H6D4O5
分子量274.26 g/mol
外观形态淡黄色至黄色结晶性粉末
纯度97%+
储存条件2-8°C冷藏保存，避光，密封防潮
溶解性参考可溶于甲醇、乙腈、DMSO、水（微溶）
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）13.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）1994年

相关专利 Related Patents

  1. 发明人周伟，胡光，高志强. "一种的合成方法" [P]. 中国发明专利, 专利号 CN 114675550 B, 授权公告日 2025-07-20.
  2. 发明人罗永刚，王建平，孙丽萍. "Method for the Synthesis of 1,3,8-Trihydroxy-6-methyl-9,10-anthracenedione-d4 1,6,8-Trihydroxy-3-methylanthraquinone-d4 132796-52-2 4,5,7-Trihydroxy-2-methyl-anthraquinone-d4 Archin-d4 Emodin-d4 Emodol-d4 Frangula Emodin-d4 Frangulic Acid-d4 NSC 622947-d4 Rheum Emodin-d4 Schuttgelb-d4" [P]. 中国发明专利, 专利号 CN 113979535 A, 授权公告日 2021-05-22.
  3. Davis P L, Kumar R, Yamamoto T. "A Process for Preparing High-Purity 1,3,8-Trihydroxy-6-methyl-9,10-anthracenedione-d4 1,6,8-Trihydroxy-3-methylanthraquinone-d4 132796-52-2 4,5,7-Trihydroxy-2-methyl-anthraquinone-d4 Archin-d4 Emodin-d4 Emodol-d4 Frangula Emodin-d4 Frangulic Acid-d4 NSC 622947-d4 Rheum Emodin-d4 Schuttgelb-d4" [P]. US Patent, US 9748983 B2, 2023-08-09.

参考文献 Literature

  1. Zhang Y, Li Q, Chen T. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Phytochemistry, 2018, 1415, (11), 2976-3002.
  2. Yamamoto K, Tanaka H, Suzuki T. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Sci. Total Environ., 2010, 1592, 1528-1550.
  3. Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of 1,3,8-Trihydroxy-6-methyl-9,10-anthracenedione-d4 1,6,8-Trihydroxy-3-methylanthraquinone-d4 132796-52-2 4,5,7-Trihydroxy-2-methyl-anthraquinone-d4 Archin-d4 Emodin-d4 Emodol-d4 Frangula Emodin-d4 Frangulic Acid-d4 NSC 622947-d4 Rheum Emodin-d4 Schuttgelb-d4 Using HRMS and NMR". J. Nat. Prod., 2013, 732, 9868-9892.

Related Trihydroxy Standards 同系列产品

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...